Insulin detemir versus insulin glargine for type 2 diabetes mellitus.

ABSTRACT:

Background

Chronically elevated blood glucose levels are associated with significant morbidity and mortality. Many diabetes patients will eventually require insulin treatment to maintain good glycaemic control. There are still uncertainties about the optimal insulin treatment regimens for type 2 diabetes, but the long-acting insulin analogues seem beneficial. Several reviews have compared either insulin detemir or insulin glargine to NPH insulin, but research directly comparing both insulin analogues is limited.

Objectives

To assess the effects of insulin detemir and insulin glargine compared with each other in the treatment of type 2 diabetes mellitus.

Search strategy

We searched MEDLINE, EMBASE, The Cochrane Library, online registries of ongoing trials and abstract

SUBMITTER: Swinnen SG 

PROVIDER: S-EPMC6486036 | biostudies-literature | 2011 Jul

REPOSITORIES: biostudies-literature